EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 37 / No 8-9 (Août–Septembre 2021) Med Sci (Paris), 37 8-9 (2021) 779-784 References
Contraception
Open Access
Issue
Med Sci (Paris)
Volume 37, Number 8-9, Août–Septembre 2021
Contraception
Page(s) 779 - 784
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2021116
Published online 07 September 2021
  1. Faucher P. Contraception d’urgence. EMC-Gynécologie 2018; 700-A-50 : 1–9. [Google Scholar]
  2. HaspelsAA. Emergency contraception: a review. Contraception 1994 ; 50 : 101–108. [CrossRef] [PubMed] [Google Scholar]
  3. MorrisJM, VanWagenen G. Compounds interfering with ovum implantation and development. III. The role of estrogens. Am J Obstet Gynecol 1966 ; 96 : 804–801. [CrossRef] [PubMed] [Google Scholar]
  4. YuzpeAA, ThurlowHJ, RamzyI, LeyshonJI. Post coital contraception: a pilot study. J Reprod Med 1974 ; 13 : 53–61. [PubMed] [Google Scholar]
  5. KesserüE, LarrañagaA, ParadaJ. Postcoital contraception with DLnorgestrel. Contraception 1973 ; 7 : 367–379. [CrossRef] [Google Scholar]
  6. LippesJ, TatumHJ, MaulikD, Sielezny M. Postcoital copper IUDs. Adv Plan Parent 1979 ; 14 : 87–94. [Google Scholar]
  7. GlasierA, ThongKJ, DewarM, et al. Postcoital contraception with mifepristone. Lancet 1991 ; 337 : 1414–1415. [CrossRef] [Google Scholar]
  8. Finidori-LepicardJ, Schorderet-SlatkineS, HanouneJ, BaulieuEE. Steroid hormone as regulatory agent of adenylate cyclase. Inhibition by progesterone of the membrane-bound enzyme in Xenopus lævis oocytes. Nature 1981 ; 292 : 255–256. [CrossRef] [PubMed] [Google Scholar]
  9. HerrmannW, WyssR, RiondelA, PhilibertD, TeutschG, SakizE, BaulieuEE. The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy. CR Séances Acad Sci III 1982 ; 294 : 933–938. [Google Scholar]
  10. CreininMD, SchlaffW, ArcherDF, et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 2006 ; 108 : 1089–1097. [PubMed] [Google Scholar]
  11. RichterR.. Ein mittelzur verhue-turng der konzeption. Deutsch Med Wschr 1909 ; 35 : 1525–1527. [Google Scholar]
  12. MarguliesL.. History of intrauterine devices. Bull NY Acad Med 1975 ; 51 : 662–667. [Google Scholar]
  13. BurnhillMS. The rise and fall and rise of the IUD. Am J Gynecol Health 1989 ; 3 : 6–10. [PubMed] [Google Scholar]
  14. GlasierA, ThongKJ, DewarM, et al. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med 1992 ; 327 : 1041–1044. [PubMed] [Google Scholar]
  15. GrimesDA, CookRJ. Mifepristone (RU 486) - an abortifacient to prevent abortion?. N Engl J Med 1992 ; 327 : 1088–1089. [PubMed] [Google Scholar]
  16. TurokDK, GodfreyEM, WojdylaD, et al. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle. Hum Reprod 2013 ; 28 : 2672–2676. [PubMed] [Google Scholar]
  17. ClelandK, ZhuH, GoldstuckN, et al. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod 2012 ; 27 : 1994–2000. [PubMed] [Google Scholar]
  18. BlackKI. Developments and challenges in emergency contraception. Best Pract Res Clin Obstet Gynaecol 2009 ; 23 : 221–231. [PubMed] [Google Scholar]
  19. INPES (Institut national de prévention et d’éducation pour la santé), AFSSAPS (Agence française de sécurité sanitaire des produits de santé), ANAES (Agence nationale d’accréditation et d’évaluation en santé). Stratégies de choix des méthodes contraceptives chez la femme. Recommandations pour la pratique clinique. Paris : Agence Nationale d’Accréditation et d’Évaluation en Santé, 2004 : 234 p. [Google Scholar]
  20. MishellDR, Jr. Intrauterine devices: mechanisms of action, safety, and efficacy. Contraception 1998 ; 58 : S45–S53. [Google Scholar]
  21. Chabbert-BuffetN, MarretH, AgostiniA, et al. Contraception : recommandations pour la pratique clinique du CNGOF. Gynecol Obstet Fertil Senol 2018 ; 46 : 760–776. [PubMed] [Google Scholar]
  22. TurokDK, SandersJN, ThompsonIS, et al. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study. Contraception 2016 ; 93 : 526–532. [PubMed] [Google Scholar]
  23. Turok DK, Gero A, Simmons RG, et al. Levonorgestrel vs copper intrauterine devices for emergency contraception. N Engl J Med 2021; 384 : 335–44. [PubMed] [Google Scholar]
  24. TrussellJ, EllertsonC, StewartF. The effectiveness of the Yuzpe regimen of emergency contraception. Fam Plann Perspect 1996 ; 28 : 58–56. [PubMed] [Google Scholar]
  25. RodriguezMI, GodfreyEM, WardenM, CurtisKM. Prevention and management of nausea and vomiting with emergency contraception: a systematic review. Contraception 2013 ; 87 : 583–589. [PubMed] [Google Scholar]
  26. GlasierA.. Emergency postcoital contraception. N Engl J Med 1997 ; 337 : 1058–1064. [PubMed] [Google Scholar]
  27. Task Force on Postovulatory Methods of Fertility RegulationRandomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998 ; 352 : 428–433. [PubMed] [Google Scholar]
  28. Von HertzenH, PiaggioG, DingJ, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002 ; 360 : 1803–1810. [PubMed] [Google Scholar]
  29. ThominA, KellerV, DaraïE, et al. Consequences of emergency contraceptives: the adverse effects. Expert Opin Drug Saf 2014 ; 13 : 893–902. [PubMed] [Google Scholar]
  30. Nicolussi S, Drewe J, Butterweck V, et al. Clinical relevance of St. John’s wort drug interactions revisited. Br J Pharmacol 2020; 177 : 1212–26. [PubMed] [Google Scholar]
  31. GlasierA, CameronST, BlitheD, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception 2011 ; 84 : 363–367. [CrossRef] [PubMed] [Google Scholar]
  32. CroxattoHB, BracheV, PavezM, et al. Pituitary-ovarian function following the standard Levonorgestrel emergency contraceptive dose or a single 075-mg dose given on the days preceding ovulation. Contraception 2004 ; 70 : 442–450. [PubMed] [Google Scholar]
  33. BracheV, CochonL, DeniaudM, et al. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens. Contraception 2013 ; 88 : 611–618. [PubMed] [Google Scholar]
  34. MarionsL, CekanSZ, BygdemanM, et al. Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function. Contraception 2004 ; 69 : 373–377. [PubMed] [Google Scholar]
  35. Gemzell-DanielssonK, MandlI, MarionsL. Mechanisms of action of mifepristone when used for emergency contraception. Contraception 2003 ; 68 : 471–476. [PubMed] [Google Scholar]
  36. NallasamyS, KimJ, Sitruk-WareR, BagchiM, BagchiI. Ulipristal blocks ovulation by inhibiting progesterone receptor-dependent pathways intrinsic to the ovary. Reprod Sci 2013 ; 20 : 371–381. [PubMed] [Google Scholar]
  37. StrattonP, LevensED, HartogB, PiquionJ, WeiQ, MerinoM, NiemanLK. Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914. Fertil Steril 2010 ; 93 : 2035–2041. [PubMed] [Google Scholar]
  38. BergerC, BoggavarapuNR, MenezesJ, LalitkumarPG, Gemzell-DanielssonK. Effects of ulipristal acetate on human embryo attachment and endometrial cell gene expression in an in vitro co-culture system. Hum Reprod 2015 ; 30 : 800–811. [PubMed] [Google Scholar]
  39. LevyDP, JagerM, KappN, AbitbolJL. Ulipristal acetate for emergency contraception: postmarketing experience after use by more than 1 million women. Contraception 2014 ; 89 : 431–433. [PubMed] [Google Scholar]
  40. GlasierAF, CameronST, FinePM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet 2010 ; 375 : 555–562. [PubMed] [Google Scholar]
  41. MoreauC, TrussellJ. Results from pooled Phase III studies of ulipristal acetate for emergency contraception. Contraception 2012 ; 86 : 673–680. [CrossRef] [PubMed] [Google Scholar]
  42. BracheV, CochonL, DuijkersIJ, et al. A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception. Hum Reprod 2015 ; 30 : 2785–2793. [PubMed] [Google Scholar]
  43. DuffyDM. Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway. Hum Reprod Update 2015 ; 21 : 652–670. [PubMed] [Google Scholar]
  44. WangPH, HorngHC, ChenYJ, et al. Effect of a selective nonsteroidal anti-inflammatory drug, celecoxib, on the reproductive function of female mice. J Chin Med Assoc 2007 ; 70 : 245–248. [PubMed] [Google Scholar]
  45. McCannNC, LynchTJ, KimSO, et al. The COX-2 inhibitor meloxicam prevents pregnancy when administered as an emergency contraceptive to nonhuman primates. Contraception 2013 ; 88 : 744–748. [PubMed] [Google Scholar]
  46. MassaiMR, ForcelledoML, BracheV, et al. Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception?. A pilot study. Hum Reprod 2007 ; 22 : 434–439. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.